nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—Peripheral ischaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0534	0.0542	CcSEcCtD
Dihydroergotamine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0513	0.052	CcSEcCtD
Dihydroergotamine—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0409	0.0415	CcSEcCtD
Dihydroergotamine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0403	0.0409	CcSEcCtD
Dihydroergotamine—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0331	0.0336	CcSEcCtD
Dihydroergotamine—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0273	0.0277	CcSEcCtD
Dihydroergotamine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0242	0.0246	CcSEcCtD
Dihydroergotamine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.0239	0.0242	CcSEcCtD
Dihydroergotamine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0225	0.0228	CcSEcCtD
Dihydroergotamine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0217	0.0221	CcSEcCtD
Dihydroergotamine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0215	CcSEcCtD
Dihydroergotamine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0198	CcSEcCtD
Dihydroergotamine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0189	0.0192	CcSEcCtD
Dihydroergotamine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0173	CcSEcCtD
Dihydroergotamine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0172	CcSEcCtD
Dihydroergotamine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0157	0.0159	CcSEcCtD
Dihydroergotamine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0156	CcSEcCtD
Dihydroergotamine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0153	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0152	CcSEcCtD
Dihydroergotamine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0141	CcSEcCtD
Dihydroergotamine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0129	CcSEcCtD
Dihydroergotamine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0127	CcSEcCtD
Dihydroergotamine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0124	CcSEcCtD
Dihydroergotamine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0122	CcSEcCtD
Dihydroergotamine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0121	CcSEcCtD
Dihydroergotamine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0119	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0115	CcSEcCtD
Dihydroergotamine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0115	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0109	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0108	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0108	CcSEcCtD
Dihydroergotamine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0104	CcSEcCtD
Dihydroergotamine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0104	CcSEcCtD
Dihydroergotamine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00981	0.00996	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00974	0.00988	CcSEcCtD
Dihydroergotamine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00971	0.00986	CcSEcCtD
Dihydroergotamine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00943	0.00957	CcSEcCtD
Dihydroergotamine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.00925	0.625	CbGbCtD
Dihydroergotamine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00912	0.00926	CcSEcCtD
Dihydroergotamine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00908	0.00922	CcSEcCtD
Dihydroergotamine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00878	0.00891	CcSEcCtD
Dihydroergotamine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.00849	CcSEcCtD
Dihydroergotamine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00827	0.0084	CcSEcCtD
Dihydroergotamine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00819	0.00831	CcSEcCtD
Dihydroergotamine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.0081	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0079	0.00802	CcSEcCtD
Dihydroergotamine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00783	0.00795	CcSEcCtD
Dihydroergotamine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00768	0.0078	CcSEcCtD
Dihydroergotamine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00765	0.00777	CcSEcCtD
Dihydroergotamine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00736	0.00747	CcSEcCtD
Dihydroergotamine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00725	0.00736	CcSEcCtD
Dihydroergotamine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00725	0.00736	CcSEcCtD
Dihydroergotamine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00723	0.00734	CcSEcCtD
Dihydroergotamine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00717	0.00727	CcSEcCtD
Dihydroergotamine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00709	0.0072	CcSEcCtD
Dihydroergotamine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00701	0.00712	CcSEcCtD
Dihydroergotamine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.00706	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.00682	CcSEcCtD
Dihydroergotamine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00663	0.00673	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00633	0.00643	CcSEcCtD
Dihydroergotamine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.00638	CcSEcCtD
Dihydroergotamine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00634	CcSEcCtD
Dihydroergotamine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0062	0.00629	CcSEcCtD
Dihydroergotamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.00627	CcSEcCtD
Dihydroergotamine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.00621	CcSEcCtD
Dihydroergotamine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00604	0.00614	CcSEcCtD
Dihydroergotamine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.00608	CcSEcCtD
Dihydroergotamine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.00604	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.00582	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.00577	CcSEcCtD
Dihydroergotamine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.375	CbGbCtD
Dihydroergotamine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.00561	CcSEcCtD
Dihydroergotamine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00558	CcSEcCtD
Dihydroergotamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00558	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00512	0.0052	CcSEcCtD
Dihydroergotamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.00506	CcSEcCtD
Dihydroergotamine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00499	CcSEcCtD
Dihydroergotamine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00483	CcSEcCtD
Dihydroergotamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00467	CcSEcCtD
Dihydroergotamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00449	CcSEcCtD
Dihydroergotamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00438	0.00445	CcSEcCtD
Dihydroergotamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00438	0.00445	CcSEcCtD
Dihydroergotamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00442	CcSEcCtD
Dihydroergotamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00419	CcSEcCtD
